title: Simple and Sensitive High-Performance Liquid Chromatography (HPLC) Method with UV Detection for Mycophenolic Acid Assay in Human Plasma. Application to a Bioequivalence Study.
abstract: OBJECTIVE
  A simple and available reversed-phase high performance liquid chromatography (HPLC) method with UV detection has been developed and validated for mycophenolic acid (MPA) assay in human plasma.
  
  
  METHODS
  MPA was extracted from plasma with protein precipitation method by acetonitrile: percholeric acid: methanol (75:5:20 v/v/v). The drug separation was achieved using a C8 analytical column and a mobile phase of 0.1M triethylammonium phosphate (pH=5.4)-acetonitril (65:35, v/v), with a flow rate of 1.5 ml/min. The detection wavelength was 304 nm. Limit of detection (LOD) of the method was determined as the lowest MPA concentration producing a signal-to-noise (S/N) ratio of about 3. Limit of quantitation (LOQ) was determined as the lowest MPA concentration capable of being quantitated with enough accuracy and precision.
  
  
  RESULTS
  The method showed significant linear response-concentration relationship throughout the MPA concentration range of 0.2-10 µg/ml. A typical linear regression equation of the method was: y = 8.5523 x + 0.094, with x and y representing MPA concentration (in µg/ml) and peak height respectively, and the regression coefficient (r) of 0.9816. The average within-run and between-run variations of 7.81 and 4.78 percent. The average drug recovery from plasma was 95.24 percent throughout the linear concentration range. The limits of detection (LOD) and quantitation (LOQ) of the method were 0.05 and 0.2 µg/ml, respectively. The practical applicability of the method was proven throughout a bioequivalence study.
  
  
  CONCLUSIONS
  The results showed the acceptable degree of linearity, sensitivity, precision, accuracy and recovery for the method. The method was used successfully for quantitation of MPA in plasma samples of healthy volunteers throughout a bioequivalence study.
authors.affiliation: Department of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
authors.forename: Hossein
authors.initials: H
authors.lastname: Danafar
authors.affiliation: Department of Pharmaceutics, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
authors.forename: Mehrdad
authors.initials: M
authors.lastname: Hamidi
keywords: Mycophenolic acid (MPA); Mycophenolic acid (MPA) assay; Reversed-phase HPLC
references.citation: Clin J Am Soc Nephrol. 2007 Sep;2(5):968-75
references.pmid: 17702723
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):554-61
references.pmid: 17336168
references.citation: Chin Med J (Engl). 2012 Dec;125(23 ):4226-32
references.pmid: 23217391
references.citation: Am J Transplant. 2007 Jul;7(7):1822-31
references.pmid: 17532750
references.citation: J Pharm Biomed Anal. 2004 Nov 15;36(3):649-51
references.pmid: 15522544
references.citation: Ther Drug Monit. 2006 Jun;28(3):402-6
references.pmid: 16778726
references.citation: Ther Drug Monit. 2009 Dec;31(6):717-26
references.pmid: 19809389
references.citation: Liver Transpl. 2004 Apr;10 (4):492-502
references.pmid: 15048791
references.citation: Clin Pharmacokinet. 2007;46(1):13-58
references.pmid: 17201457
references.citation: Clin Chem. 2001 Aug;47(8):1485-8
references.pmid: 11468247
references.citation: Biomed Chromatogr. 2006 Apr;20(4):319-26
references.pmid: 16145659
references.citation: Am J Transplant. 2003 May;3(5):534-42
references.pmid: 12752309
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 15;780(1):21-6
references.pmid: 12383476
references.citation: J Heart Lung Transplant. 2003 May;22(5):587-90
references.pmid: 12742423
references.citation: Clin Pharmacokinet. 2005;44(5):525-38
references.pmid: 15871638
references.citation: Pharmacotherapy. 1997 Nov-Dec;17 (6):1178-97
references.pmid: 9399601
references.citation: Clin J Am Soc Nephrol. 2007 Jan;2(1):184-91
references.pmid: 17699403